Contralateral breast cancer risk with radiation therapy in BRCA mutation carriers: what do we tell patients?

被引:0
|
作者
Lee, Minna K. [1 ]
Robson, Mark E. [2 ,3 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Breast Serv, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, 300 E 66th St,Room 813, New York, NY 10065 USA
来源
基金
美国国家卫生研究院;
关键词
RADIOTHERAPY; MASTECTOMY;
D O I
10.1093/jnci/djad129
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1243 / 1245
页数:3
相关论文
共 50 条
  • [1] Therapeutic radiation for breast cancer in BRCA mutation carriers and contralateral breast cancer (CBC) risk
    Moore, H. C.
    Wesolowski, R.
    Choueiri, T. K.
    Rybicki, L.
    Shealy, A. G.
    Casey, G.
    Weng, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Risk of ipsilateral and contralateral cancer in BRCA mutation carriers with breast cancer
    Green L.
    Meric-Bernstam F.
    Current Breast Cancer Reports, 2011, 3 (3) : 151 - 155
  • [3] Radiation exposure and breast cancer risk for BRCA mutation carriers
    Goldfrank, DJ
    Chuai, S
    Cajal, TRY
    Lee, JB
    Alonso, MC
    Diez, O
    Baiget, M
    Kauff, ND
    Offit, K
    Bernstein, JL
    Robson, ME
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S23 - S23
  • [4] Aromatase inhibitors and the risk of contralateral breast cancer in BRCA mutation carriers.
    Shafaee, Maryam Nemati
    Gutierrez-Barrera, Angelica M.
    Lin, Heather Y.
    Arun, Banu
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [5] Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
    Graeser, Monika K.
    Engel, Christoph
    Rhiem, Kerstin
    Gadzicki, Dorothea
    Bick, Ulrich
    Kast, Karin
    Froster, Ursula G.
    Schlehe, Bettina
    Bechtold, Astrid
    Arnold, Norbert
    Preisler-Adams, Sabine
    Nestle-Kraemling, Carolin
    Zaino, Mohammad
    Loeffler, Markus
    Kiechle, Marion
    Meindl, Alfons
    Varga, Dominic
    Schmutzler, Rita K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) : 5887 - 5892
  • [6] Contralateral breast cancer risk in patients with or without BRCA mutation
    Kang, Eunhye
    Jung, Ji-Jung
    Yeoh, Hyunsu
    Lim, Changjin
    Kim, Jang-Il
    Chun, Jung Whan
    Kim, Hong-Kyu
    Lee, Han-Byoel
    Han, Wonshik
    Moon, Hyeong-Gon
    CANCER RESEARCH, 2023, 83 (05)
  • [7] Increased risk of contralateral breast cancer for BRCA1 mutation carriers compared to BRCA2 mutation carriers
    Graeser, M.
    Engel, C.
    Zaino, M.
    Schmutzler, R.
    ONKOLOGIE, 2008, 31 : 28 - 28
  • [8] Aromatase inhibitors and contralateral breast cancer in BRCA mutation carriers
    Shafaee, Maryam Nemati
    Goutsouliak, Kristina
    Lin, Heather
    Bevers, Therese B.
    Gutierrez-Barrera, Angelica
    Bondy, Melissa
    Arun, Banu
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 196 (01) : 143 - 152
  • [9] Aromatase inhibitors and contralateral breast cancer in BRCA mutation carriers
    Maryam Nemati Shafaee
    Kristina Goutsouliak
    Heather Lin
    Therese B. Bevers
    Angelica Gutierrez-Barrera
    Melissa Bondy
    Banu Arun
    Breast Cancer Research and Treatment, 2022, 196 : 143 - 152
  • [10] Risk of contralateral breast cancer amongst BRCA1/2 mutation carriers
    Basu, Narendra Nath
    Evans, D. Gareth
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S1066 - S1069